ArticleFrontiers in pharmacology2020

Mechanisms of Action of the KCa2-Negative Modulator AP30663, a Novel Compound in Development for Treatment of Atrial Fibrillation in Man.

Bo Hjorth Bentzen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.